Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Van Hemelryk, A."'
Autor:
Van Hemelryk, Annelies1 (AUTHOR) a.vanhemelryk@erasmusmc.nl, Erkens-Schulze, Sigrun1 (AUTHOR) s.erkens-schulze@erasmusmc.nl, Lim, Lifani1 (AUTHOR) c.deridder@erasmusmc.nl, de Ridder, Corrina M. A.1 (AUTHOR) d.stuurman@erasmusmc.nl, Stuurman, Debra C.1 (AUTHOR) g.jenster@erasmusmc.nl, Jenster, Guido W.1 (AUTHOR), van Royen, Martin E.2 (AUTHOR) m.vanroyen@erasmusmc.nl, van Weerden, Wytske M.1 (AUTHOR) w.vanweerden@erasmusmc.nl
Publikováno v:
Cells (2073-4409). May2023, Vol. 12 Issue 10, p1377. 16p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Van Hemelryk, Annelies1 (AUTHOR), Tomljanovic, Ingrid1,2 (AUTHOR), de Ridder, Corrina M. A.1 (AUTHOR), Stuurman, Debra C.1 (AUTHOR), Teubel, Wilma J.1 (AUTHOR), Erkens-Schulze, Sigrun1 (AUTHOR), Verhoef, Esther I.3 (AUTHOR), Remmers, Sebastiaan1 (AUTHOR), Mahes, Amrish J.2 (AUTHOR), van Leenders, Geert J. L. H.3 (AUTHOR), van Royen, Martin E.3 (AUTHOR), van de Werken, Harmen J. G.1,4,5 (AUTHOR), Grudniewska, Magda2 (AUTHOR), Jenster, Guido W.1 (AUTHOR), van Weerden, Wytske M.1 (AUTHOR) w.vanweerden@erasmusmc.nl
Publikováno v:
Cells (2073-4409). Nov2022, Vol. 11 Issue 22, p3632. 21p.
Autor:
Annelies Van Hemelryk, Sigrun Erkens-Schulze, Lifani Lim, Corrina M. A. de Ridder, Debra C. Stuurman, Guido W. Jenster, Martin E. van Royen, Wytske M. van Weerden
Publikováno v:
Cells, Vol 12, Iss 10, p 1377 (2023)
Tumor organoids have been pushed forward as advanced model systems for in vitro oncology drug testing, with the eventual goal to direct personalized cancer treatments. However, drug testing efforts suffer from a large variation in experimental condit
Externí odkaz:
https://doaj.org/article/d9b94a9c25aa4cd88b4d7be85f2dcdf8
Publikováno v:
In Current Opinion in Endocrine and Metabolic Research February 2020 10:7-15
Autor:
Van Hemelryk, Roger
Publikováno v:
National Provisioner. Feb2013, Vol. 227 Issue 2, p1-1. 1/2p. 1 Color Photograph.
Autor:
Annelies Van Hemelryk, Ingrid Tomljanovic, Corrina M. A. de Ridder, Debra C. Stuurman, Wilma J. Teubel, Sigrun Erkens-Schulze, Esther I. Verhoef, Sebastiaan Remmers, Amrish J. Mahes, Geert J. L. H. van Leenders, Martin E. van Royen, Harmen J. G. van de Werken, Magda Grudniewska, Guido W. Jenster, Wytske M. van Weerden
Publikováno v:
Cells, Vol 11, Iss 22, p 3632 (2022)
Castration-resistant prostate cancer (CRPC) remains an incurable and lethal malignancy. The development of new CRPC treatment strategies is strongly impeded by the scarcity of representative, scalable and transferable preclinical models of advanced,
Externí odkaz:
https://doaj.org/article/9ed70a04355a4fed8481dd542b4ecb2b
Autor:
Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Van Hemelryk A; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., de Ridder C; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Stuurman D; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Erkens-Schulze S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van 't Geloof S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Teubel WJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, The Netherlands., Martens-Uzunova ES; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Royen ME; Department of Pathology, Erasmus University Medical Center Rotterdam, The Netherlands., de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 May 02; Vol. 23 (5), pp. 711-720.
Autor:
Annelies Van Hemelryk, Lisanne Mout, Sigrun Erkens-Schulze, Pim J. French, Wytske M. van Weerden, Martin E. van Royen
Publikováno v:
Biomolecules, Vol 11, Iss 11, p 1572 (2021)
Organoid-based studies have revolutionized in vitro preclinical research and hold great promise for the cancer research field, including prostate cancer (PCa). However, experimental variability in organoid drug testing complicates reproducibility. Fo
Externí odkaz:
https://doaj.org/article/721bef334d5b4664922d111ed7466a0c
Autor:
Van Hemelryk, Annelies, De Meerleer, Gert, Ost, Piet, Poelaert, Filip, De Gersem, Werner, Decaestecker, Karel, De Visschere, Pieter, Fonteyne, Valérie
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1 October 2016 96(2):323-332